– Professor Bobbie Farsides, Professor of Clinical and Biomedical Ethics, Brighton and Sussex Medical School
– Dr Agomoni Ganguli-Mitra, Lecturer and Chancellor’s Fellow in Bioethics and Global Health Ethics, University of Edinburgh School of Law
– Professor Dr Steffen Augsberg, Professor of Public Law, University of Giessen
Chair:Hugh Whittall, Director, Nuffield Council on Bioethics
Governments around the world have started to modify restrictions introduced to slow the spread of COVID-19. In the absence of an effective treatment or vaccine, attention has turned to other ways of monitoring and managing the spread of the disease.
One of the options being widely discussed is a system of antibody testing to assess an individual’s risk of being infected and transmitting the virus to others – which could subsequently be used as the basis for an “immunity certification” scheme.
Join us for a discussion on the ethical questions raised by COVID-19 antibody testing and immunity certification.